Sign Up Today and Learn More About Pear Therapeutics Stock
Invest in or calculate the value of your shares in Pear Therapeutics or other pre-IPO companies through EquityZen's platform.
Pear Therapeutics Stock
Digital Therapeutics Platform
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform aims to combine novel digital interventions with drugs to enhance efficacy, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payers. The company has three FDA-approved products for substance use disorders, opioid use disorders, and insomnia. Pear Therapeutics was founded in 2013 and is headquartered in Boston, Massachusetts.
About Pear Therapeutics Stock
Founded
2013
Headquarters
Boston, MA, US
Notable Investor
Trustbridge Partners
Total Funding
274M
Industries
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to help treat disease and enhance the efficacy of pharmaceuticals. The company's platform aims to combine novel digital interventions with drugs to enhance efficacy, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payers. The company has three FDA-approved products for substance use disorders, opioid use disorders, and insomnia.Â
Pear Therapeutics was founded in 2013 and is headquartered in Boston, Massachusetts. Notable investors include Softbank Vision Fund, Temasek Holdings, and Perceptive Advisors.
Pear Therapeutics Press Mentions
Stay in the know about the latest news on Pear Therapeutics
Massachusetts offers Medicaid coverage for Pear Therapeutics’ digital therapeutics
massdevice • Oct, 13 2021
MassHealth to cover Pear Therapeutics' reSET and reSET-O
shar • Oct, 13 2021
Pear Therapeutics touts real-world data for reSET-O prescription digital therapeutic
drugdeliverybusiness • Sep, 16 2021
Pear Therapeutics touts 9-month data for reSET-O
drugdeliverybusiness • Jul, 14 2021
Pear Therapeutics to go public via SPAC merger
ow • Jun, 22 2021
Investors in Pear Therapeutics
Discover investors in Pear Therapeutics stock and explore their portfolio companies
Pear Therapeutics Management
Leadership team at Pear Therapeutics
Chief Executive Officer
Corey McCann
Chief Financial Officer
Chris Guiffre
Join now and verify your accreditation status to gain access to:
- Pear Therapeutics current valuation
- Pear Therapeutics stock price
- Available deals in Pear Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Pear Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Pear Therapeutics through EquityZen funds. These investments are made available by existing Pear Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Pear Therapeutics stock?
Shareholders can sell their Pear Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
